CEO Kenneth L. Davis, MD, and Icahn School of Medicine Dean Dennis S. Charney, MD, Discuss the Future of Medicine During the Aspen Ideas Festival in Colorodo | Benzinga

"Both leaders recognize the “revolution in genomics” and the growing ability to personalize therapy based on an individual's biology. Both called for “open access” to clinical trial information and “open sourcing” of data repositories, as well as drug development incentives."